Revascularization
Colchicine does not improve outcomes in patients getting PCI after acute heart attack
WASHINGTON — Contradicting previous research, in a large trial of patients referred for PCI after acute MI, colchicine did not improve CV outcomes compared with placebo, according to the CLEAR SYNERGY (OASIS-9) trial presented at TCT 2024.
Shared decision-making key for invasive vs. conservative MI strategy in elderly: SENIOR-RITA
For older adults with non-STEMI, routine coronary intervention was safe but did not lower risk for death from CV causes or nonfatal MI compared with medical therapy alone, according to new data from the SENIOR-RITA trial.
Coronary implant noninferior to DES at 1 year, tied to event reduction after 6 months
The bioadaptor implant adaptable to vessel physiology was noninferior to a drug-eluting stent for target lesion failure at 1 year, and reduced event rates vs. the DES after 6 months, researchers reported.
Q&A: TCAR, which transformed carotid artery revascularization, reaches 100,000 procedures
Revascularization of carotid arteries has always been a challenging procedure, and both carotid surgery and transfemoral carotid stenting can lead to severe complications.
Benefits of aspirin for secondary prevention in ASCVD seemingly equal in men vs. women
Patient sex had seemingly no effect on the safety and efficacy of aspirin for patients with atherosclerotic CVD, according to secondary analysis of the ADAPTABLE trial published in JAMA Cardiology.
Fewer women undergo revascularization for heart attack vs. men
Despite larger declines in STEMI and non-STEMI events from 2011 to 2018, women received proportionately fewer revascularization procedures and had a higher STEMI mortality rate vs. men, researchers reported.
Revascularization rates higher with ‘CT first’ diagnosis of chest pain
Read-world data showed that more patients underwent subsequent revascularization after “CT first” evaluation for chest pain vs. other functional testing strategies, researchers reported.
Expert panel: IVUS can benefit patients needing peripheral revascularization
Compared with angiography, IVUS may improve care and outcomes of patients requiring interventional peripheral revascularization, according to an expert consensus roundtable sponsored by several medical societies.
Revascularization after treatment of in-stent restenosis high after 10 years
SAN FRANCISCO — Among patients treated for drug-eluting in-stent restenosis, the revascularization rate at 10 years was high, according to the results of a post hoc analysis of the ISAR-DESIRE 3 trial presented at TCT 2023.
Statins for primary prevention provide similar protection among older vs. younger adults
Older individuals appeared to derive similar magnitude of LDL lowering and CV risk reduction from statin therapy initiation vs. younger patients, according to data from a large Danish study.